Area of research
Pharmaceutical Science · Molecular Biology
Research interest
Research interests include Advancements in Transdermal Drug Delivery, Lipid Membrane Structure and Behavior, Bee Products Chemical Analysis, and Surfactants and Colloidal Systems.
Multiscale simulation of stratum corneum lipid mixtures: effects of ceramide headgroups on structural organization and hydrogen bonding networks.
Clinical Validation of Imaging Biomarkers in Mycosis Fungoides.
Remodeling of the cell membrane-associated protein pool affects adhesive membrane properties in filaggrin insufficient keratinocytes and impacts distinct cellular and organellar functions.
From prebiotics to engineered microbes: microbe-inspired treatments for atopic dermatitis.
Multi-omics profiling of chronic immune-mediated skin diseases: SKINERGY protocol and strategic evaluation.
Dissecting key contributions of T<sub>H</sub>2 and T<sub>H</sub>17 cytokines to atopic dermatitis pathophysiology.
Fluoxetine exerts anti-proliferative effect in human epidermal keratinocytes.
Synthetically programmed antioxidant delivery by a domesticated skin commensal.
NETSKINMODELS: A European Network for Skin Engineering and Modeling.
Flower dependent trafficking of lamellar bodies facilitates maturation of the epidermal barrier.
Investigating the Effect of Enzymatically-Derived Blackcurrant Extract on Skin Staphylococci Using an In Vitro Human <i>Stratum Corneum</i> Model.
Multi-omic triangulation identifies molecular candidates of atopic dermatitis severity
Epidermal barrier function in dry, flaky and sensitive skin: A narrative review.
Blockade of interleukin-13 signalling improves skin barrier function and biology in patients with moderate-to-severe atopic dermatitis.
The Aryl Hydrocarbon Receptor Regulates Epidermal Differentiation through Transient Activation of TFAP2A
Lesional Psoriasis is Associated With Alterations in the Stratum Corneum Ceramide Profile and Concomitant Decreases in Barrier Function.
Electrical Impedance Spectroscopy Quantifies Skin Barrier Function in Organotypic In Vitro Epidermis Models.
Targeting Skin Barrier Function in Atopic Dermatitis.
Investigations into the FLG Null Phenotype: Showcasing the Methodology for CRISPR/Cas9 Editing of Human Keratinocytes
Novel methodologies for host-microbe interactions and microbiome-targeted therapeutics in 3D organotypic skin models.
Gram-positive anaerobic cocci guard skin homeostasis by regulating host-defense mechanisms
Lead optimization of aryl hydrocarbon receptor ligands for treatment of inflammatory skin disorders.
Keratinocyte signaling in atopic dermatitis: Investigations in organotypic skin models toward clinical application.
CYSRT1: An Antimicrobial Epidermal Protein that Can Interact with Late Cornified Envelope Proteins.
The Ah Receptor from Toxicity to Therapeutics: Report from the 5th AHR Meeting at Penn State University, USA, June 2022.
Advanced methodology for bacterial colonization of 3D organotypic epidermal models: a gateway to long-term host-microbe interaction and intervention studies
Identification of Keratinocyte Mitogens: Implications for Hyperproliferation in Psoriasis and Atopic Dermatitis
Requirements and expectations of high-quality biomarkers for atopic dermatitis and psoriasis in 2021-a two-round Delphi survey among international experts.
Carboxamide Derivatives Are Potential Therapeutic AHR Ligands for Restoring IL-4 Mediated Repression of Epidermal Differentiation Proteins.
Antimicrobial Late Cornified Envelope Proteins: The Psoriasis Risk Factor Deletion of LCE3B/C Genes Affects Microbiota Composition